These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16105047)

  • 1. Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
    Vanegas V; Ferrebuz A; Quiroz Y; Rodríguez-Iturbe B
    Kidney Int; 2005 Sep; 68(3):1161-70. PubMed ID: 16105047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
    Rodríguez-Iturbe B; Pons H; Quiroz Y; Gordon K; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ
    Kidney Int; 2001 Jun; 59(6):2222-32. PubMed ID: 11380825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
    Romero F; Rodríguez-Iturbe B; Parra G; González L; Herrera-Acosta J; Tapia E
    Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
    Bravo Y; Quiroz Y; Ferrebuz A; Vaziri ND; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F616-23. PubMed ID: 17567935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.
    Quiroz Y; Pons H; Gordon KL; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F38-47. PubMed ID: 11399644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.
    Bloudícková S; Rajnoch J; Lodererová A; Honsová E; Viklický O
    Kidney Blood Press Res; 2006; 29(1):60-6. PubMed ID: 16645304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?
    Liu WH; Tang NN; Zhang QD
    Chin Med J (Engl); 2009 Jan; 122(2):199-204. PubMed ID: 19187647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats.
    Ardiles LG; Ehrenfeld P; Quiroz Y; Rodriguez-Iturbe B; Herrera-Acosta J; Mezzano S; Figueroa CD
    Kidney Blood Press Res; 2002; 25(5):289-95. PubMed ID: 12435874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.
    Rodríguez-Iturbe B; Quiroz Y; Nava M; Bonet L; Chávez M; Herrera-Acosta J; Johnson RJ; Pons HA
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F191-201. PubMed ID: 11788432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells.
    Alvarez V; Quiroz Y; Nava M; Pons H; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1132-41. PubMed ID: 12372790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in renal wrap hypertension.
    Denton KM; Anderson WP
    Hypertension; 1985; 7(6 Pt 1):893-8. PubMed ID: 3000937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.
    Franco M; Martínez F; Quiroz Y; Galicia O; Bautista R; Johnson RJ; Rodríguez-Iturbe B
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R251-6. PubMed ID: 17475676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.
    Pechman KR; Basile DP; Lund H; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1234-9. PubMed ID: 18256138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal venous wedge pressure in renal wrap hypertension in rabbits.
    Denton KM; Anderson WP
    Clin Exp Pharmacol Physiol; 1989 Aug; 16(8):681-4. PubMed ID: 2507203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of mycophenolate mofetil in ischemic acute renal failure in rats].
    Chávez-Velásquez M; Pons H; Medina M; Quiroz Y; Parra G; Herrera J
    Nefrologia; 2007; 27(4):448-58. PubMed ID: 17944582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.
    Ventura CG; Coimbra TM; de Campos SB; de Castro I; Yu L; Seguro AC
    J Am Soc Nephrol; 2002 Oct; 13(10):2524-33. PubMed ID: 12239241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.
    Tapia E; Franco M; Sánchez-Lozada LG; Soto V; Avila-Casado C; Santamaría J; Quiroz Y; Rodríguez-Iturbe B; Herrera-Acosta J
    Kidney Int; 2003 Mar; 63(3):994-1002. PubMed ID: 12631080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.